Home » Topics » BioWorld Science

BioWorld Science
RSS

MT-332: Pharma Mar's novel cytotoxic metabolite

June 28, 1996

Antitumor epidioxymanadic acid described by Pharma Mar

June 28, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Marimastat enters U.S. and U.K. phase III trial

June 28, 1996

Therapeutic melanoma vaccine in phase I

June 28, 1996

Eulexin is FDA-approved for new indication

June 28, 1996

More antitumor taxoids

June 28, 1996

LHRH antagonists from TAP Holdings

June 28, 1996

Antitumor taxoids revealed

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.